Furthermore, the expression of HDAC1 has been reported to correlate with the progression and prognosis of gastrointestinal malignancies (21, 22); and HDAC3 also has been suggested as a prognostic marker in gastric (21), colorectal (23), and pancreatic cancer (24). This evidence concerns the gene HDAC3 and pancreatic neoplasm.